Cargando…

A reduced M1-like/M2-like ratio of macrophages in healthy adipose tissue expansion during SGLT2 inhibition

The adipose tissue includes various stromal cells, such as preadipocytes, endothelial cells, fibroblasts, and immune cells, which are involved in adipose tissue functions. We previously reported that, in obese mice, the sodium–glucose cotransporter 2 inhibitor ipragliflozin (Ipra) promoted the expan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyachi, Yasutaka, Tsuchiya, Kyoichiro, Shiba, Kumiko, Mori, Kentaro, Komiya, Chikara, Ogasawara, Naomi, Ogawa, Yoshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208395/ https://www.ncbi.nlm.nih.gov/pubmed/30382157 http://dx.doi.org/10.1038/s41598-018-34305-x

Ejemplares similares

Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH
por: Shiba, Kumiko, et al.
Publicado: (2018)

Ipragliflozin-induced adipose expansion inhibits cuff-induced vascular remodeling in mice
por: Mori, Kentaro, et al.
Publicado: (2019)

Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction
por: Komiya, Chikara, et al.
Publicado: (2016)

Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis
por: Komiya, Chikara, et al.
Publicado: (2017)

Ipragliflozin Ameliorates Diabetic Nephropathy Associated with Perirenal Adipose Expansion in Mice
por: Okuma, Hideyuki, et al.
Publicado: (2021)

Amelioration of diabetic nephropathy by SGLT2 inhibitors independent of its glucose-lowering effect: A possible role of SGLT2 in mesangial cells
por: Maki, Toshinobu, et al.
Publicado: (2019)

Differential effect of canagliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor, on slow and fast skeletal muscles from nondiabetic mice
por: Otsuka, Hiroko, et al.
Publicado: (2022)

Forkhead box class O family member proteins: The biology and pathophysiological roles in diabetes
por: Tsuchiya, Kyoichiro, et al.
Publicado: (2017)

Melanocortin-4 receptor in macrophages attenuated angiotensin II-induced abdominal aortic aneurysm in mice
por: Mori, Kentaro, et al.
Publicado: (2023)

EMMY: The continued expansion of clinical applications of SGLT2 inhibitors
por: Kotit, Susy
Publicado: (2023)

It is likely that m$_{t}$ $<$ m$_{W}$
por: Halzen, Francis
Publicado: (1986)

HNF1A Mutations and Beta Cell Dysfunction in Diabetes
por: Miyachi, Yasutaka, et al.
Publicado: (2022)

CD11c+ M1-like macrophages (MΦs) but not CD206+ M2-like MΦ are involved in folliculogenesis in mice ovary
por: Ono, Yosuke, et al.
Publicado: (2018)

mTORC1 and SGLT2 Inhibitors—A Therapeutic Perspective for Diabetic Cardiomyopathy
por: Saha, Sumit, et al.
Publicado: (2023)

Effect of Sodium Glucose Cotransporter 2 Inhibitors With Low SGLT2/SGLT1 Selectivity on Circulating Glucagon-Like Peptide 1 Levels in Type 2 Diabetes Mellitus
por: Takebayashi, Kohzo, et al.
Publicado: (2017)

M1-like, but not M0- or M2-like, macrophages, reduce RSV infection of primary bronchial epithelial cells in a media-dependent fashion
por: Ronaghan, Natalie J., et al.
Publicado: (2022)

The piston for the 2-m chamber expansion system
por: CERN PhotoLab
Publicado: (1963)

M2‐like macrophages serve as a niche for adipocyte progenitors in adipose tissue
por: Nawaz, Allah, et al.
Publicado: (2019)

Cellular Mechanisms of Hepatoprotection Mediated by M2-Like Macrophages
por: Bai, Li, et al.
Publicado: (2018)

CD206(+) M2-like macrophages regulate systemic glucose metabolism by inhibiting proliferation of adipocyte progenitors
por: Nawaz, Allah, et al.
Publicado: (2017)

The Mincle ligand trehalose dibehenate differentially modulates M1‐like and M2‐like macrophage phenotype and function via Syk signaling
por: Kodar, Kristel, et al.
Publicado: (2017)

TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype
por: Quero, Lilian, et al.
Publicado: (2017)

Age-associated decline of monocyte insulin sensitivity in diabetic and healthy individuals
por: Nakamura, Suguru, et al.
Publicado: (2021)

RANK Ligand Helps Immunity to Leishmania major by Skewing M2-Like Into M1 Macrophages
por: Rigoni, Thaís S., et al.
Publicado: (2020)

SGLT2 and cancer
por: Wright, Ernest M.
Publicado: (2020)

Pseudo Chediak Higashi-like inclusions in myeloblasts in AML-M2
por: Sharma, Sunita, et al.
Publicado: (2013)

CD206+ M2-Like Macrophages Are Essential for Successful Implantation
por: Ono, Yosuke, et al.
Publicado: (2020)

HCV inhibits M2a, M2b and M2c macrophage polarization via HCV core protein engagement with Toll-like receptor 2
por: Zhao, Shixing, et al.
Publicado: (2022)

Mannosyl-Recognizing Receptors Induce an M1-Like Phenotype in Macrophages of Susceptible Mice but an M2-Like Phenotype in Mice Resistant to a Fungal Infection
por: Feriotti, Claudia, et al.
Publicado: (2013)

HIF-1α-Overexpressing Mesenchymal Stem Cells Attenuate Colitis by Regulating M1-like Macrophages Polarization toward M2-like Macrophages
por: Zhu, Wenya, et al.
Publicado: (2023)

Lactoferrin-Containing Immunocomplexes Drive the Conversion of Human Macrophages from M2- into M1-like Phenotype
por: Gao, Chen-Hui, et al.
Publicado: (2018)

Withholding of M-CSF Supplement Reprograms Macrophages to M2-Like via Endogenous CSF-1 Activation
por: Chen, Yu-Chih, et al.
Publicado: (2021)

A TCR-like CAR Promotes Sensitive Antigen Recognition and Controlled T-cell Expansion Upon mRNA Vaccination
por: Birtel, Matthias, et al.
Publicado: (2022)

Promiscuous evolution of Group A Streptococcal M and M-like proteins
por: Frost, Hannah R., et al.
Publicado: (2023)

Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
por: Ghezzi, Chiara, et al.
Publicado: (2018)

SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes
por: Schaub, Jennifer A., et al.
Publicado: (2023)

HIF-PHD inhibitor regulates the function of group2 innate lymphoid cells and polarization of M2 macrophages
por: Nagashima, Ryuichi, et al.
Publicado: (2023)

Resistin-Like Molecule-β Inhibits SGLT-1 Activity and Enhances GLUT2-Dependent Jejunal Glucose Transport
por: Krimi, Rim Belharbi, et al.
Publicado: (2009)

SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
por: Sattar, Naveed, et al.
Publicado: (2016)

Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States
por: Nicholas, Susanne B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1e15615uq9a8cmdphtojo7g4oe